Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6578)
All Articles published online
|
Publishing Process of This Article
|
May 28, 2014 (publication date) through Jan 9, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hohla F, Winder T, Greil R, Rick FG, Block NL, Schally AV. Targeted therapy in advanced metastatic colorectal cancer: Current concepts and perspectives. World J Gastroenterol 2014; 20(20): 6102-6112 [PMID: 24876732 DOI: 10.3748/wjg.v20.i20.6102] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i20/6102.htm |
| Number | Citing Articles |
| 1 |
Yosi Gilad, Michael Firer, Gary Gellerman. Recent Innovations in Peptide Based Targeted Drug Delivery to Cancer Cells. Biomedicines 2016; 4(2): 11 doi: 10.3390/biomedicines4020011
|
| 2 |
William A. Hammond, Abhisek Swaika, Kabir Mody. Pharmacologic resistance in colorectal cancer: a review. Therapeutic Advances in Medical Oncology 2016; 8(1): 57 doi: 10.1177/1758834015614530
|
| 3 |
Luigia Panariello, Marianna Donnarumma, Rosario Vincenzo Iaffaioli, Paolo Chiodini, Maria Carmela Annunziata, Tiziana Peduto, Gabriella Fabbrocini. Skin Toxicities During Colorectal Cancer Chemotherapy: Incidence and Pearls of Treatment in Our Experience. Clinical Colorectal Cancer 2020; 19(4): e235 doi: 10.1016/j.clcc.2020.05.006
|
| 4 |
Andrew V Schally, Roberto Perez, Norman L Block, Ferenc G Rick. Potentiating effects of GHRH analogs on the response to chemotherapy. Cell Cycle 2015; 14(5): 699 doi: 10.1080/15384101.2015.1010893
|
| 5 |
MOON HEE LEE, SU-HYUN HONG, CHEOL PARK, GI-YOUNG KIM, SUN-HEE LEEM, SUNG HYUN CHOI, YOUNG-SAM KEUM, JIN WON HYUN, TAEG KYU KWON, SANG HOON HONG, YUNG HYUN CHOI. Hwang-Heuk-San induces apoptosis in HCT116 human colorectal cancer cells through the ROS-mediated activation of caspases and the inactivation of the PI3K/Akt signaling pathway. Oncology Reports 2016; 36(1): 205 doi: 10.3892/or.2016.4812
|
| 6 |
Nicole Golob-Schwarzl, Caroline Schweiger, Carina Koller, Stefanie Krassnig, Margit Gogg-Kamerer, Nadine Gantenbein, Anna M. Toeglhofer, Christina Wodlej, Helmut Bergler, Brigitte Pertschy, Stefan Uranitsch, Magdalena Holter, Amin El-Heliebi, Julia Fuchs, Andreas Punschart, Philipp Stiegler, Marlen Keil, Jens Hoffmann, David Henderson, Hans Lehrach, Christoph Reinhard, Christian Regenbrecht, Rudolf Schicho, Peter Fickert, Sigurd Lax, Johannes Haybaeck. Separation of low and high grade colon and rectum carcinoma by eukaryotic translation initiation factors 1, 5 and 6. Oncotarget 2017; 8(60): 101224 doi: 10.18632/oncotarget.20642
|
| 7 |
Ofer Levi, Assaf Shapira, Baruch Tal, Itai Benhar, Noam Eliaz. Isolating EGFR Overexpressing Carcinoma Cells from Human Whole Blood by Bio-Ferrography. Cytometry Part B: Clinical Cytometry 2014; : n/a doi: 10.1002/cytob.21212
|
| 8 |
ZhaoHui Xu, Hui Qu, YanYing Ren, ZeZhong Gong, Hyok Ju Ri, Xin Chen. An Update on the Potential Roles of E2F Family Members in Colorectal Cancer. Cancer Management and Research 2021; : 5509 doi: 10.2147/CMAR.S320193
|
| 9 |
Vitor A. Ungaro, Cleber W. Liria, Carolina D. Romagna, Natália J. S. Costa, Karine Philippot, Liane M. Rossi, M. Teresa Machini. A green route for the synthesis of a bitter-taste dipeptide combining biocatalysis, heterogeneous metal catalysis and magnetic nanoparticles. RSC Advances 2015; 5(46): 36449 doi: 10.1039/C5RA02641E
|
| 10 |
Eszter Lajkó, Rózsa Hegedüs, Gábor Mező, László Kőhidai. Apoptotic Effects of Drug Targeting Conjugates Containing Different GnRH Analogs on Colon Carcinoma Cells. International Journal of Molecular Sciences 2019; 20(18): 4421 doi: 10.3390/ijms20184421
|
| 11 |
Xianzhe Li, Minghao Xie, Shi Yin, Zhizhong Xiong, Chaobin Mao, Fengxiang Zhang, Huaxian Chen, Longyang Jin, Ping Lan, Lei Lian. Identification and Validation of a Six Immune-Related Genes Signature for Predicting Prognosis in Patients With Stage II Colorectal Cancer. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.666003
|
| 12 |
Shuai Wang, ChunHui Yin, XinYan Zhang, ZhiMei Shang, LiMin Huang, Nan Luo, AnQuan Wang, LingLing Dong, HongXing Liu, JingYan Zhu. Conversion to resectability using transcatheter arterial chemoembolization alternating with mFOLFOX6 in patients with colorectal liver metastases. Journal of Research in Medical Sciences 2019; 24(1): 92 doi: 10.4103/jrms.JRMS_879_16
|
| 13 |
Klara Fodor, Nikoletta Dobos, Andrew Schally, Zita Steiber, Gabor Olah, Eva Sipos, Lorant Szekvolgyi, Gabor Halmos. The targeted LHRH analog AEZS-108 alters expression of genes related to angiogenesis and development of metastasis in uveal melanoma. Oncotarget 2020; 11(2): 175 doi: 10.18632/oncotarget.27431
|
| 14 |
Xiaofeng Peng, Kangming Pan, Wenli Zhao, Jianzhu Zhang, Shicheng Yuan, Xiang Wen, Wenquan Zhou, Zhijin Yu. NPTX1 inhibits colon cancer cell proliferation through down‐regulating cyclin A2 and CDK2 expression. Cell Biology International 2018; 42(5): 589 doi: 10.1002/cbin.10935
|
| 15 |
Defeng Liu, Shihao Peng, Yangyang Li, Tao Guo. Circ-MFN2 Positively Regulates the Proliferation, Metastasis, and Radioresistance of Colorectal Cancer by Regulating the miR-574-3p/IGF1R Signaling Axis. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.671337
|
| 16 |
Rosemeire M. Kanashiro-Takeuchi, Luca Szalontay, Andrew V. Schally, Lauro M. Takeuchi, Petra Popovics, Miklos Jaszberenyi, Irving Vidaurre, Marta Zarandi, Ren-Zhi Cai, Norman L. Block, Joshua M. Hare, Ferenc G. Rick. New therapeutic approach to heart failure due to myocardial infarction based on targeting growth hormone-releasing hormone receptor. Oncotarget 2015; 6(12): 9728 doi: 10.18632/oncotarget.3303
|
| 17 |
Kexin Shen, Ying Zhang, Jianxun Ding, Haishan Zhang. c(RGDfC)-decorated micelle as nanocarrier for targeting therapeutic of colon cancer. Journal of Controlled Release 2015; 213: e66 doi: 10.1016/j.jconrel.2015.05.109
|
| 18 |
Kexin Shen, Di Li, Jingjing Guan, Jianxun Ding, Zhongtang Wang, Jingkai Gu, Tongjun Liu, Xuesi Chen. Targeted sustained delivery of antineoplastic agent with multicomponent polylactide stereocomplex micelle. Nanomedicine: Nanotechnology, Biology and Medicine 2017; 13(3): 1279 doi: 10.1016/j.nano.2016.12.022
|
| 19 |
Cédric Seignez, Amandine Martin, Claire-Emmanuelle Rollet, Cindy Racoeur, Alessandra Scagliarini, Jean-François Jeannin, Ali Bettaieb, Catherine Paul. Senescence of tumor cells induced by oxaliplatin increases the efficiency of a lipid A immunotherapy via the recruitment of neutrophils. Oncotarget 2014; 5(22): 11442 doi: 10.18632/oncotarget.2556
|
| 20 |
Ji Sung Kim, Yong Guk Kim, Eun Jae Park, Boyeong Kim, Hong Kyung Lee, Jin Tae Hong, Youngsoo Kim, Sang-Bae Han. Cell-based Immunotherapy for Colorectal Cancer with Cytokine-induced Killer Cells. Immune Network 2016; 16(2): 99 doi: 10.4110/in.2016.16.2.99
|
| 21 |
Kira S Sheinerman, Samuil Umansky. Universal screening test based on analysis of circulating organ-enriched microRNAs: a novel approach to diagnostic screening. Expert Review of Molecular Diagnostics 2015; 15(3): 329 doi: 10.1586/14737159.2014.973858
|
| 22 |
Jingde Chen, Li Li, Zhuqing Zhou, Shijun Yu, Yandong Li, Yong Gao. FAPP2 promotes tumor cell growth in human colon cancer through activation of Wnt signaling. Experimental Cell Research 2019; 374(1): 12 doi: 10.1016/j.yexcr.2018.11.002
|
| 23 |
Wojciech Jelski, Barbara Mroczko. <p>Biochemical Markers of Colorectal Cancer – Present and Future</p>. Cancer Management and Research 2020; : 4789 doi: 10.2147/CMAR.S253369
|
| 24 |
Petra Popovics, Andrew V. Schally, Luca Szalontay, Norman L. Block, Ferenc G. Rick. Targeted cytotoxic analog of luteinizing hormone-releasing hormone (LHRH), AEZS-108 (AN-152), inhibits the growth of DU-145 human castration-resistant prostate cancerin vivoandin vitrothrough elevating p21 and ROS levels. Oncotarget 2014; 5(12): 4567 doi: 10.18632/oncotarget.2146
|
| 25 |
Carmen Ili, Kurt Buchegger, Hannah Demond, Juan Castillo-Fernandez, Gavin Kelsey, Louise Zanella, Michel Abanto, Ismael Riquelme, Jaime López, Tamara Viscarra, Patricia García, Enrique Bellolio, David Saavedra, Priscilla Brebi. Landscape of Genome-Wide DNA Methylation of Colorectal Cancer Metastasis. Cancers 2020; 12(9): 2710 doi: 10.3390/cancers12092710
|
| 26 |
Elif Kadife, Thomas Michael Benjamin Ware, Rodney Brian Luwor, Steven Tuck Foo Chan, Kulmira Nurgali, Paul Vincent Senior. Effects of EphB4 receptor expression on colorectal cancer cells, tumor growth, vascularization and composition. Acta Oncologica 2018; 57(8): 1043 doi: 10.1080/0284186X.2018.1429650
|
| 27 |
Hataw Jalal Taher, Fouad Kamel. Fusobacterium nucleatum-Mediated Alteration in Expression of VEGF and CCL3 Genes and KRAS Mutation in Colorectal Cancer Patients. Jundishapur Journal of Microbiology 2023; 16(6) doi: 10.5812/jjm-136914
|
| 28 |
Tijen Temiz Kaya, Ahmet Altun, Nergiz Hacer Turgut, Hilmi Ataseven, Gokhan Koyluoglu. Effects of a Multikinase Inhibitor Motesanib (AMG 706) Alone and Combined with the Selective DuP-697 COX-2 Inhibitor on Colorectal Cancer Cells. Asian Pacific Journal of Cancer Prevention 2016; 17(3): 1103 doi: 10.7314/APJCP.2016.17.3.1103
|
| 29 |
Ying Liu, Su An, Richard Ward, Yang Yang, Xiao-Xi Guo, Wei Li, Tian-Rui Xu. G protein-coupled receptors as promising cancer targets. Cancer Letters 2016; 376(2): 226 doi: 10.1016/j.canlet.2016.03.031
|
| 30 |
Anca Chelariu-Raicu, Alpa Nick, Renata Urban, Mary Gordinier, Carola Leuschner, Linda Bavisotto, Graziela Zibetti Dal Molin, John K. Whisnant, Robert L. Coleman. A multicenter open-label randomized phase II trial of paclitaxel plus EP-100, a novel LHRH receptor-targeted, membrane-disrupting peptide, versus paclitaxel alone for refractory or recurrent ovarian cancer. Gynecologic Oncology 2021; 160(2): 418 doi: 10.1016/j.ygyno.2020.11.013
|
| 31 |
Dominick Latremouille-Viau, Jane Chang, Annie Guerin, Sherry Shi, Ed Wang, Justin Yu, Christopher Ngai. The economic burden of common adverse events associated with metastatic colorectal cancer treatment in the United States. Journal of Medical Economics 2017; 20(1): 54 doi: 10.1080/13696998.2016.1225577
|
| 32 |
Roberto Perez, Andrew V. Schally, Petra Popovics, Renzhi Cai, Wei Sha, Ricardo Rincon, Ferenc G. Rick. Antagonistic analogs of growth hormone-releasing hormone increase the efficacy of treatment of triple negative breast cancer in nude mice with doxorubicin; A preclinical study. Oncoscience 2014; 1(10): 665 doi: 10.18632/oncoscience.92
|
| 33 |
Paola Moreno, Irene Ramos-Álvarez, Terry W. Moody, Robert T. Jensen. Bombesin related peptides/receptors and their promising therapeutic roles in cancer imaging, targeting and treatment. Expert Opinion on Therapeutic Targets 2016; 20(9): 1055 doi: 10.1517/14728222.2016.1164694
|
| 34 |
Janette Beech, Theodora Germetaki, Mary Judge, Nina Paton, Joanne Collins, Abigail Garbutt, Michael Braun, Jill Fenwick, Mark P Saunders. Management and Grading of EGFR Inhibitor-Induced Cutaneous Toxicity. Future Oncology 2018; 14(24): 2531 doi: 10.2217/fon-2018-0187
|
| 35 |
Martin Pesta, Vlastimil Kulda, Andrea Narsanska, Jakub Fichtl, Ondrej Topolcan. May CTC technologies promote better cancer management?. EPMA Journal 2015; 6(1) doi: 10.1186/s13167-014-0023-x
|
| 36 |
Vânia Diogo, Joana Teixeira, Patrícia M.A. Silva, Hassan Bousbaa. Spindle Assembly Checkpoint as a Potential Target in Colorectal Cancer: Current Status and Future Perspectives. Clinical Colorectal Cancer 2017; 16(1): 1 doi: 10.1016/j.clcc.2016.06.006
|